Regulation of collagenase activity in the ulcerating cornea by cyclic-AMP

Michael B. Berman, H. Dwight Cavanagh, Janet Gage

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Dibutyryl cyclic-AMP (DBcAMP) and theophylline partially inhibit the appearance of collagenase activity when added to cultures of ulcerating rabbit corneas. Drug treatment with DBcAMP also inhibits degradation of collagen in the explanted corneas as measured by hydroxyproline in the media. The hydrolysis product of DBcAMP, 5′-adenosine monophosphate (5′ AMP) is itself very effective in suppressing collagenase activity and the degradation of explant collagen. The mechanism(s) of the drug effects is not yet known but it is possible that the drugs affect the synthesis and/or the secretion of collagenase. The results suggest that "first messengers" exist which can prevent the secretion of corneal collagenase by raising endogenous cAMP in corneal cells through stimulation of the adenyl cyclase system. Eventual successful treatment of corneal ulceration might well require pharmacologic intervention at multiple levels: the biosynthesis, secretion, activation and activity of collagenase.

Original languageEnglish (US)
Pages (from-to)209-218
Number of pages10
JournalExperimental Eye Research
Volume22
Issue number3
DOIs
StatePublished - 1976

Fingerprint

Collagenases
Cyclic AMP
Cornea
Bucladesine
Collagen
Pharmaceutical Preparations
Hydroxyproline
Adenosine Monophosphate
Theophylline
Adenylyl Cyclases
Hydrolysis
Rabbits

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Regulation of collagenase activity in the ulcerating cornea by cyclic-AMP. / Berman, Michael B.; Cavanagh, H. Dwight; Gage, Janet.

In: Experimental Eye Research, Vol. 22, No. 3, 1976, p. 209-218.

Research output: Contribution to journalArticle

@article{084ec999be714a08ae4f1d4d7a4b0e4e,
title = "Regulation of collagenase activity in the ulcerating cornea by cyclic-AMP",
abstract = "Dibutyryl cyclic-AMP (DBcAMP) and theophylline partially inhibit the appearance of collagenase activity when added to cultures of ulcerating rabbit corneas. Drug treatment with DBcAMP also inhibits degradation of collagen in the explanted corneas as measured by hydroxyproline in the media. The hydrolysis product of DBcAMP, 5′-adenosine monophosphate (5′ AMP) is itself very effective in suppressing collagenase activity and the degradation of explant collagen. The mechanism(s) of the drug effects is not yet known but it is possible that the drugs affect the synthesis and/or the secretion of collagenase. The results suggest that {"}first messengers{"} exist which can prevent the secretion of corneal collagenase by raising endogenous cAMP in corneal cells through stimulation of the adenyl cyclase system. Eventual successful treatment of corneal ulceration might well require pharmacologic intervention at multiple levels: the biosynthesis, secretion, activation and activity of collagenase.",
author = "Berman, {Michael B.} and Cavanagh, {H. Dwight} and Janet Gage",
year = "1976",
doi = "10.1016/0014-4835(76)90048-8",
language = "English (US)",
volume = "22",
pages = "209--218",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Regulation of collagenase activity in the ulcerating cornea by cyclic-AMP

AU - Berman, Michael B.

AU - Cavanagh, H. Dwight

AU - Gage, Janet

PY - 1976

Y1 - 1976

N2 - Dibutyryl cyclic-AMP (DBcAMP) and theophylline partially inhibit the appearance of collagenase activity when added to cultures of ulcerating rabbit corneas. Drug treatment with DBcAMP also inhibits degradation of collagen in the explanted corneas as measured by hydroxyproline in the media. The hydrolysis product of DBcAMP, 5′-adenosine monophosphate (5′ AMP) is itself very effective in suppressing collagenase activity and the degradation of explant collagen. The mechanism(s) of the drug effects is not yet known but it is possible that the drugs affect the synthesis and/or the secretion of collagenase. The results suggest that "first messengers" exist which can prevent the secretion of corneal collagenase by raising endogenous cAMP in corneal cells through stimulation of the adenyl cyclase system. Eventual successful treatment of corneal ulceration might well require pharmacologic intervention at multiple levels: the biosynthesis, secretion, activation and activity of collagenase.

AB - Dibutyryl cyclic-AMP (DBcAMP) and theophylline partially inhibit the appearance of collagenase activity when added to cultures of ulcerating rabbit corneas. Drug treatment with DBcAMP also inhibits degradation of collagen in the explanted corneas as measured by hydroxyproline in the media. The hydrolysis product of DBcAMP, 5′-adenosine monophosphate (5′ AMP) is itself very effective in suppressing collagenase activity and the degradation of explant collagen. The mechanism(s) of the drug effects is not yet known but it is possible that the drugs affect the synthesis and/or the secretion of collagenase. The results suggest that "first messengers" exist which can prevent the secretion of corneal collagenase by raising endogenous cAMP in corneal cells through stimulation of the adenyl cyclase system. Eventual successful treatment of corneal ulceration might well require pharmacologic intervention at multiple levels: the biosynthesis, secretion, activation and activity of collagenase.

UR - http://www.scopus.com/inward/record.url?scp=0017113087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017113087&partnerID=8YFLogxK

U2 - 10.1016/0014-4835(76)90048-8

DO - 10.1016/0014-4835(76)90048-8

M3 - Article

C2 - 178517

AN - SCOPUS:0017113087

VL - 22

SP - 209

EP - 218

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

IS - 3

ER -